Endocrine Society GUIDELINES Bundle (free trial)

Pediatric Obesity

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1140160

Contents of this Issue


Page 27 of 27

106 Commerce Street, Suite 105 Lake Mary, FL 32746 TEL: 407.878.7606 • FAX: 407.878.7611 Order additional copies, at GuidelineCentral.com Copyright © 2017 All rights reserved ESPEDOB1733 Disclaimer is Guideline attempts to define principles of practice that should produce high-quality patient care. It focuses on the needs of primary care practice, but also is applicable to providers at all levels. is Guideline should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. e ultimate judgment concerning the propriety of any course of conduct must be made by the clinician aer consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool. Source Styne DM, Arslanian SA, Connor EL, Farooqi IS, Murad MH, Silverstein JH, Yanovski JA. Pediatric Obesity—Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. March 2017, 102(3):1–49. Abbreviations ACTH, adrenocorticotropic hormone; AOR, adjusted odds ratio; BMI, body mass index; BDNF, brain-derived neurotrophic factor; BP, blood pressure; CI, confidence interval; CNS, central nervous system; DNA, Deoxyribonucleic Acid; ES, Endocrine Society; FT4, (plasma) free thyroxine; GH, growth hormone; HDL, high-density lipoprotein; HR, heart rate; HTN, hypertension; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; IQR, interquartile range; IV, intravenous; LAGB, laparoscopic adjustable gastric banding ; LDL, low-density lipoprotein; MAOI, monoamine oxidase inhibitor; MVI, multivitamins; NAFLD, non-alcoholic fatty liver disease; OGTT, oral glucose tolerance test (1.75 g/kg, maximum 75 g ); PCOS, polycystic ovary syndrome; POMC, proopiomelanocortin; RCT, randomized controlled trial; RYGB, Roux-en-Y gastric bypass; SBP, systolic blood pressure; SKOT, Scottish Childhood Obesity Treatment Trial; SMD, standardized mean difference; SNRI, selective serotonin-norepinephrine reuptake inhibitors; SSRI, selective serotonin-reuptake inhibitors; T2DM, type 2 diabetes mellitus; TV, television; HDL, high-density lipoprotein; T4, thyroxine; TG, triglyceride; VO 2 , oxygen consumption; VSG, vertical sleeve gastrectomy Grading System Strength of Recommendation 1 = strong 2 = weak U = ungraded Quality of Evidence ⊕⊕⊕⊕ = high ⊕⊕⊕ = moderate ⊕⊕ = low ⊕ = very low

Articles in this issue

Links on this page

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Pediatric Obesity